4IOI
Meditope-enabled trastuzumab in complex with CQFDLSTRRLKC
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2012-11-01 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 53.310, 105.110, 117.620 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 33.579 - 1.950 |
R-factor | 0.1772 |
Rwork | 0.176 |
R-free | 0.20440 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.007 |
RMSD bond angle | 1.090 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX ((phenix.refine: 1.8.1_1168)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 33.580 | 2.000 |
High resolution limit [Å] | 1.950 | 1.950 |
Rmerge | 0.047 | 0.452 |
Number of reflections | 44759 | |
<I/σ(I)> | 23.6 | 3.4 |
Completeness [%] | 91.7 | 98.4 |
Redundancy | 4.5 | 4.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7.2 | 293 | 20% PEG 3350, 25 mM NaCl, 50 mM Hepes, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K |